CEBPB Antikörper (AA 50-100)
Kurzübersicht für CEBPB Antikörper (AA 50-100) (ABIN2617780)
Target
Alle CEBPB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 50-100
-
Marke
- IHC-plus™
-
Spezifität
- Region between residue 50 and 100 of human CCAAT/Enhancer Binding Protein (C/EBP), beta using the numbering given in entry NP_005185.2 (GeneID 1051).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (N-Term) antibody
KO Validated CEBPB Reaktivität: Human WB, IHC, IP, IHC (p), IF, ICC, ChIP Wirt: Kaninchen Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (pThr235) antibodyCEBPB Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 150-250) antibodyCEBPB Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) antibodyCEBPB Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 3H9 unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (Internal Region) antibodyCEBPB Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 271-298) antibodyCEBPB Reaktivität: Human WB, ELISA, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 271-298), (C-Term) antibodyCEBPB Reaktivität: Human WB, IHC (p), FACS Wirt: Kaninchen Polyclonal RB20651 unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 68-81) antibodyVerified CEBPB Reaktivität: Human, Maus, Schwein WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 201-250), (pThr235) antibodyCEBPB Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (pSer235) antibodyCEBPB Reaktivität: Human, Maus, Ratte, Rind (Kuh), Schwein WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
Approved: IF (1:250 - 1:2000), IHC, IHC-P (5 μg/mL), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Osteosarcoma, Prostate Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
-
Andere Bezeichnung
- C/EBP beta / CEBPB
-
Hintergrund
-
Name/Gene ID: CEBPB
Synonyms: CEBPB, C/EBP-beta, C/EBP beta, CRP2, LAP, Liver activator protein, Nuclear factor NF-IL6, IL6DBP, TCF5, NFIL6, TCF-5, Transcription factor 5, NF-IL6 -
Gen-ID
- 1051
-
Pathways
- Interferon-gamma Pathway, Autophagie, Brown Fat Cell Differentiation
Target
-
